Imagine being a pediatric kidney transplant patient and having to miss school or extracurricular activities because of clinic appointments and routine blood tests.

At the close of the 2014-2016 West Africa Ebola crisis, the Paul G. Allen Foundation identified diagnostic gaps as one of the major deficiencies that had contributed to the outbreak¡¯s spread.

Brigham and Women¡¯s Hospital investigators are working on a test that could either diagnose or predict Alzheimer¡¯s disease before symptoms appear.

A long-awaited and massive study with major implications for the liquid biopsy market is slated to start next year.

Oxford HighQ has received ¡ê2.1 million in seed funding to commercialize components of a quantum computing technology developed at Oxford University that can be used to develop improved chemical and nanoparticle sensing technologies.

An innovative new medical instrumentation and biotechnology company known as Daxor just published some exciting new data for their flagship technology, the BVA-100 blood volume analyzer.

A cell-by-cell search for cardiac stem cells has come up empty, suggesting that previous studies hinting at the existence of cardiac stem cells were mistaken.

Biocartis announced it has entered into an agreement with AstraZeneca.

Agilent technologies has announced a new expansion of its Little Island facility in cork, Ireland.

Mesa Biotech recently said that the US Food and Drug Administration has cleared and CLIA-waived the company's Accula RSV respiratory syncytial virus test for diagnostic use in both children and adults.

Novacyt announced recently that its molecular testing division, Primerdesign, has inked an exclusive supply agreement with Genesis Diagnostics.

Stilla Technologies announced recently that it has completed a €16 million ($18.3 million) Series A financing round led by Illumina Ventures.

Bionano Genomics reported a 3 percent increase in third-quarter revenues after the market close recently.

PerkinElmer Genomics has chosen BioDiscovery's NxClinical software for genomic data analysis for its services, BioDiscovery announced recently.

WuXi NextCode said today that it has closed a $200 million Series C financing round.